Company intelligence / Profile preview

UBS Securities

Beijing, China

Ownership: Private
Development stage: Other

Overview

UBS Securities Co. Limited is a subsidiary of UBS Group AG and the first foreign-invested fully-licensed securities firm in China. It offers a range of financial services, including securities brokerage, investment consultancy, financial advisory, and wealth management. However, it is not directly involved in life science, biotech, or pharma activities. Instead, UBS’s broader activities include supporting these sectors through its asset management and investment banking divisions. The company operates primarily from Beijing, China, leveraging its global network to provide customized financial solutions.

Industry: Investors

Beyond the preview

Go deeper on UBS Securities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBS Securities.

Explore the full profile